Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT05523856
Eligibility Criteria:
Inclusion Criteria:
* Age between 50 and 75 years.
* Clinical stage T1 or T2, N0/Nx and M0/Mx.
* Gleason ≤6 or 7 (if 3+4 with T1c).
* Prostate-Specific Antigen (PSA) ≤ 10 .
* To be treated with active surveillance, robot-assisted radical prostatectomy, intensity-modulated radiotherapy or real-time brachytherapy
Exclusion Criteria:
* Body mass index \> 33.
* Neoadjuvant hormonal treatment.
* Previous pelvic treatments.
* Presence of serious comorbidities.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
50 Years
Maximum Age:
75 Years
Study:
NCT05523856
Study Brief:
Protocol Section:
NCT05523856